The AI-ready database for multi-omics

In the race to unlock the potential of multi-omics data for transformative bench-to-bedside medicine, organizations face hurdles with traditional pipelines and tools. Cumbersome workflows, data transfers and conversions fall short and can’t keep pace with the scale, speed, and diversity demanded by today’s multi-omics research and AI-based precision medicine. Moreover, the use of disparate tools for different data modalities creates governance and discoverability headaches for R&D IT and infrastructure teams.

Enter TileDB, an innovative multimodal database system tailored to the complex demands of life sciences. Embraced by 10 of the top 20 pharmaceutical companies and numerous pioneering biotechs in AI-based drug development and precision medicine, TileDB delivers unparalleled performance and enables rapid delivery of data products at Atlas- and Biobank-scale to bioinformaticians, clinicians, and end-users across all omics domains.

Discover how TileDB tackles data challenges in population genomics, single-cell analysis, and biomedical imaging. Join us to witness how TileDB is reshaping the landscape for multi-omics research.